CAPTRUST FINANCIAL ADVISORS - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$3,375,816
-17.2%
89,449
+0.0%
0.01%
-18.8%
Q2 2023$4,074,953
+13.0%
89,441
+0.6%
0.02%0.0%
Q1 2023$3,605,573
-19.4%
88,895
+1.3%
0.02%
-30.4%
Q4 2022$4,472,721
+0.8%
87,752
+6.5%
0.02%
-11.5%
Q3 2022$4,436,000
-12.2%
82,359
+5.2%
0.03%
-21.2%
Q2 2022$5,052,000
-6.3%
78,314
+13.0%
0.03%
-5.7%
Q1 2022$5,394,000
-5.3%
69,318
+4.8%
0.04%
-10.3%
Q4 2021$5,696,000
+9.5%
66,147
+2.6%
0.04%
-9.3%
Q3 2021$5,204,000
-1.9%
64,473
-1.9%
0.04%
-12.2%
Q2 2021$5,307,000
-8.6%
65,696
-4.3%
0.05%
-22.2%
Q1 2021$5,808,000
+14.2%
68,668
+8.7%
0.06%
-6.0%
Q4 2020$5,087,000
-10.1%
63,186
-11.0%
0.07%
-28.7%
Q3 2020$5,658,000
-8.1%
70,970
+0.6%
0.09%
-6.9%
Q2 2020$6,157,000
+12.8%
70,513
+1.6%
0.10%
-15.8%
Q1 2020$5,460,000
-9.9%
69,411
-1.6%
0.12%
+25.0%
Q4 2019$6,060,000
+82.6%
70,567
+86.4%
0.10%
-17.9%
Q3 2019$3,319,000
+3.6%
37,851
-2.9%
0.12%
-1.7%
Q2 2019$3,203,000
+5.0%
38,998
+4.2%
0.12%
-4.0%
Q1 2019$3,051,000
+20.9%
37,439
-2.1%
0.12%
-8.1%
Q4 2018$2,524,000
-15.2%
38,244
-0.6%
0.14%
+1.5%
Q3 2018$2,975,000
+750.0%
38,491
+713.9%
0.13%
+600.0%
Q2 2018$350,000
+26.4%
4,729
+8.3%
0.02%
+11.8%
Q1 2018$277,000
-1.4%
4,365
+0.7%
0.02%0.0%
Q4 2017$281,000
+92.5%
4,334
+91.3%
0.02%
+183.3%
Q3 2017$146,0002,2660.01%
Other shareholders
BAXTER INTL INC shareholders Q1 2023
NameSharesValueWeighting ↓
SECTOR GAMMA AS 713,500$49,895,00012.74%
Veritas Asset Management LLP 7,636,450$534,017,0007.53%
FIRST NEW YORK SECURITIES LLC /NY 154,158$10,780,269,0005.40%
Gabalex Capital Management LLC 200,000$14,981,0005.39%
Veritas Investment Management LLP 291,825$18,816,0005.32%
Tweedy, Browne Co LLC 2,543,966$177,900,0004.91%
York Capital Management Global Advisors, LLC 8,074,375$564,641,0004.78%
First Fiduciary Investment Counsel, Inc. 270,675$18,928,0004.10%
SCHARF INVESTMENTS, LLC 2,247,225$157,148,0004.03%
Osher Van de Voorde Investment Management 96,235$6,730,0003.91%
View complete list of BAXTER INTL INC shareholders